Summary
A generalized view on the mechanism of steroid hormone action is presented with special emphasis on glucocorticoids and their lymphocytolytic effects. The present knowledge on the structure and function of glucocorticoid receptors is reviewed. Following hormone binding, the receptor complex is activated to a form which is able to interact with chromatin or DNA. Several types of receptor mutants have been obtained in an animal cell culture system which allows selection of cell variants. The biochemical analysis of these mutants helped to establish a domain model of receptor structure. The quantitative effect of receptor numbers and hormone activity on lymphocytolysis is described in a cell culture model system and the results are discussed in view of the rational treatment of lymphoid neoplasia with glucocorticoids. The clinical experience with glucocorticoids alone and in combination therapy with cytostatic drugs is summarized. Our special emphasis is on acute lymphoblastic leukemia and malignant lymphoma as patients with these diseases can now be treated with remarkable success rates.
Similar content being viewed by others
Literatur
Bagley CM, De Vita VT, Berard CW, Canellos GP (1972) Advanced lymphosarcoma-Intensive cyclical combination chemotherapy with cyclophosphamide, vincristine and prednisone. Ann Int Med 76:227–234
Ballard PL, Baxter JD, Higgins SJ, Rousseau GG, Tomkins GM (1974) General presence of glucocorticoid receptors in mammalian tissues. Endocrinology 94:998–1002
Bloomfield CD, Munck AU, Smith KA (1984) Glucocorticoid receptor levels predict response to treatment in human lymphoma. In: Gurpide E, Calandra R, Levy C, Soto RJ (eds) Hormones and Cancer. AR Liss, New York, pp 223–233
Bourgeois S, Gasson JC (1985) Genetic and epigenetic basis of glucocorticoid resistance in lymphoid cell lines. In: Litwack G (ed) Biochemical Actions of Hormones 12. Academic Press, New York, pp 311–351
Bremer K, Meusers P, Brittinger G (1980) Chemotherapie der Non-Hodgkin-Lymphome. Internist 21:512–528
Clark CR (1984) The cellular distribution of steroid hormone receptors: have we got it right? Trends Biochem Sci 9:207–208
Craddock CG (1978) Corticoid-induced lymphopenia, immunosuppression, and body defense. Ann Intern Med 88:564–566
Dellweg H-G, Hotz A, Mugele K, Gehring U (1982) Active domains in wild-type and mutant glucocorticoid receptors. EMBO J 1:285–289
Dougherty TF (1952) Effects of hormones on lymphatic tissue. Physiol Rev 32:379–401
Ehrsson H, Wallin I, Nilsson S-O, Johansson B (1983) Pharmacokinetics of chlorambucil in man after administration of the free drug and its prednisolone ester. Eur J Clin Pharmacol 24:251–253
Fisher RI, DeVitta VT, Hubbard SM, Longo DL, Wesley R, Chabner BA, Young RC (1983) Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of ProMACE and MOPP chemotherapy. Ann Intern Med 98:304–309
Gale RP (1979) Advances in the treatment of acute myelogeneous leukemia. New Engl J Med 300:1189–1199
Gehring U (1980) Cell genetics of glucocorticoid responsiveness. In: Litwack G (ed) Biochemical Actions of Hormones 7, Academic Press, New York, pp 205–232
Gehring U (1984) Functional domains in wild-type and variant glucocorticoid receptors of lymphoid cells. In: Bresciani F, King RJB, Lippman ME, Namer M, Raynaud J-P (eds) Hormones and Cancer 2, Raven Press, New York, pp 245–254
Gehring U, Hotz A (1983) Photoaffinity labeling and partial proteolysis of wild-type and variant glucocorticoid receptors. Biochemistry 22:4013–4018
Gehring U, Arndt H (1985) Heteromeric nature of glucocorticoid receptors. FEBS Letters 179:138–142
Gehring U, Ulrich J, Segnitz B (1982) Lymphoma cell variants of decreased glucocorticoid sensitivity. Mol Cell Endocrinol 28:605–611
Gehring U, Mugele K, Ulrich J (1984) Cellular receptor levels and glucocorticoid responsiveness of lymphoma cells. Mol Cell Endocrinol 36:107–113
Green S, Walter P, Kumar V, Krust A, Bornert J-M, Argos P, Chambon P (1986) Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320:134–139
Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J (1986) Sequence and expression of human estrogen receptor complementary DNA. Science 231:1150–1154
Henderson ES (1969) Treatment of acute leukemia. Semin Hematol 6:271–319
Higgins SJ, Gehring U (1978) Molecular mechanism of steroid hormone action. Adv Cancer Res 28:313–397
Ho AD, Hunstein W, Ganeshaguru K, Hoffbrand AV, Brandeis W, Denk B (1982) Therapeutic and prognostic implications of glucocorticoid receptors and terminal deoxynucleotidyl transferase in acute leukemia. Leukemia Res 6:1–8
Ho AD, Stojakowits S, Pralle H, Dörner M, Hunstein W (1983) Glucocorticoid receptor level, terminal deoxynucleotidyl transferase activity and initial responsiveness to prednisone and vincristine in leukemia. Klin Wochenschr 61:455–459
Hoelzer D, Thiel E, Löffler H, Bodenstein H, Plaumann L, Büchner T, Urbanitz D, Koch P, Heimpel H, Engelhardt R, Müller U, Wendt F-C, Sodomann H, Rühl H, Herrmann F, Kaboth W, Dietzfelbinger H, Pralle H, Lunscken Ch, Hellriegel K-P, Spors S, Nowrousian RM, Fischer J, Fülle H, Mitrou PS, Pfreundschuh M, Görg Ch, Emmerich B, Queisser W, Meyer P, Labedzki L, Essers U, König H, Mainzer K, Herrmann R, Messerer D, Zwingers T (1984) Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults. Blood 64:38–47
Holbrook NJ, Bodwell JE, Jeffries M, Munck A (1983) Characterization of nonactivated and activated glucocorticoid-receptor complexes from intact rat thymus cells. J Biol Chem 158:6477–6485
Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG, Evans RM (1985) Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318:635–641
Iacobelli S, Marchetti P, De Rossi G, Mandelli F (1984) Glucocorticoid receptors and steroid sensitivity of human acute lymphoblastic leukemia. In: Gurpide E, Calandra R, Levy C, Soto RJ (eds) Hormones and Cancer. AR Liss, New York, pp 235–246
Jensen EV (1984) Intracellular localization of estrogen receptors: implications for interaction mechanism. Lab Invest 51:487–488
Laurence J, Coleman M, Allen SL, Silver RT, Pasmantier M (1982) Combination chemotherapy of advanced diffuse histiocytic lymphoma with the six-drug COP-BLAM regimen. Ann Intern Med 97:190–195
Lenhard RE Jr, Prentice RL, Owens AH Jr, Bakmeier R, Horton JH, Shnider BI, Stolbach L, Berard CW, Carbone P (1976) Combination chemotherapy of the malignant lymphomas — a controlled clinical trial. Cancer 38:1051–1059
Lippman ME (1979) Glucocorticoid receptors and effects in human lymphoid and leukemic cells. In: Baxter JD, Rousseau GG (eds) Glucocorticoid Hormone Action. Springer, Berlin Heidelberg New York, pp 377–397
Marković RD, Litwack G (1980) Activation of liver and kidney glucocorticoid-receptor complexes occurs in vivo. Arch Biochem Biophys 202:374–379
Mattsson W, von Eben F, Turesson I, Wählby S (1978) Prednimustine treatment of lymphocytic and lymphocytic-histiocytic lymphomas. Cancer 41:112–116
Medical Research Council (1966) Treatment of acute leukemia in adults: Comparison of steroid and mercaptopurine therapy, alone and in conjunction. Br Med J i:1383–1389
Munck A, Foley R (1979) Activation of steroid hormonereceptor complexes in intact target cells in physiological conditions. Nature 278:752–754
Munck A, Crabtree GR (1981) Glucocorticoid-induces lymphocyte death. In: Bowen ID, Lockshin RA (eds) Cell Death in Biology and Pathology, Chapman and Hall, London, pp 329–359
Newell DR, Calvert AH, Harrap KR, McElwain TJ (1983) Studies on the pharmacokinetics of chlorambucil and prednimustine in man. Br J Clin Pharmac 15:253–258
Pedersen-Bjergaard J, Hansen MM, Geisler CH, Nissen NI (1980) Clinical trial of prednimustine, Leo-1031, in patients with non-Hodgkin lymphomata and chronic lymphocytic leukemia previously treated with steroids and alkylating agents. Acta Med Scand 207:215–220
Pui C-H, Costlow ME, Dahl GV, Rivera G, Murphy SB (1983) Response of recurrent acute lymphoblastic leukemia to glucocorticoids: serial studies of receptor content, in vivo cytokinetic changes and clinical responses. Leukemia Res 7:747–753
Pui C-H, Ochs J, Kalwinsky KD, Costlow ME (1984) Impact of treatment efficacy on the prognostic value of glucocorticoid receptor levels in childhood acute lymphoblastic leukemia. Leukemia Res 8:345–350
Raaka BM, Samuels HH (1983) The glucocorticoid receptor in GH1 cells. J Biol Chem 258:417–425
Ranney H, Gelhorn A (1957) The effect of massive prednisone and prednisolone therapy on acute leukemia and malignant lymphomas. Ann Int Med 22:405–413
Riehm H, Gardner H, Heinze G, Langermann HJ, Odenwald E (1980) The Berlin childhood acute lymphoblastic leukemia study 1970–1976. Am J Pediat Hematol Oncol 2:299–306
Ringold GM (1985) Steroid hormone regulation of gene expression. Ann Rev Pharmacol Toxicol 25:529–566
Rousseau GG (1984) Structure and regulation of the glucocorticoid hormone receptor. Mol Cell Endocrinol 38:1–11
Sherman MR, Stevens J (1984) Structure of mammalian steroid receptors: evolving concepts and methodological developments. Ann Rev Physiol 46:83–105
Stevens J, Stevens Y-W, Haubenstock H (1983) Molecular basis of glucocorticoid resistance in experimental and human leukemia. In: Litwack G (ed) Biochemical Actions of Hormones 10, Academic Press, New York, pp 383–446
Thompson EB, Smith JR, Bourgeois S, Hormon JM (1985) Glucocorticoid receptors in human leukemias and related diseases. Klin Wochenschr 63:689–698
Vedeckis WV (1983) Subunit dissociation as a possible mechanism of glucocorticoid receptor activation. Biochemistry 22:1983–1989
Vedeckis WV (1985) Steroid hormone receptor structure in normal and neoplastic cells. In: Hollander VP (ed) Hormonally Responsive Tumors, Academic Press, New York
Weinberger C, Hollenberg SM, Rosenfeld MG, Evans RM (1985) Domain structure of human glucocorticoid receptor and its relationship to the v-erb-A oncogene product. Nature 318:670–672
Weinstein HJ, Mayer RJ, Rosenthal DS, Camitta BM, Coral FS, Nathan DG, Frei E III (1980) Treatment of acute myelogenous leukemia in children and adults. New Engl J Med 303:473–478
Weinstein HJ, Mayer RJ, Rosenthal DS, Coral FS, Camitta BM, Gelber RD (1983) Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update. Blood 62:315–319
Westphal HM, Mugele K, Beato M, Gehring U (1984) Immunochemical characterization of wild-type and variant glucocorticoid receptors by monoclonal antibodies. EMBO J 3:1493–1498
Zeller WJ, Schreiber J, Ho AD, Schmähl D, Eisenbrand G (1984) Cytostatic activity of steroid linked nitrosoureas. J Cancer Res Clin Oncol 108:164–168
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gehring, U., Ho, A.D. Klinische Relevanz von Glucocorticoid-Rezeptoren für die Behandlung lymphoider Neoplasien. Klin Wochenschr 65, 247–252 (1987). https://doi.org/10.1007/BF01773441
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01773441